Literature DB >> 27534794

Soluble epoxide hydrolase: a new therapeutic target for depression.

Kenji Hashimoto1.   

Abstract

Entities:  

Keywords:  Antidepressant; depression; inflammation; soluble epoxide hydrolase

Mesh：

Substances：

Year:  2016        PMID： 27534794     DOI： 10.1080/14728222.2016.1226284

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  11 in total

Review 1.  Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Authors:  W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha
Journal:  Neurosci Biobehav Rev       Date:  2018-02-02       Impact factor: 8.989

Review 2.  Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors:  Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2018-11-14       Impact factor: 11.685

3.  Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.

Authors:  Qian Ren; Min Ma; Jun Yang; Risa Nonaka; Akihiro Yamaguchi; Kei-Ichi Ishikawa; Kenta Kobayashi; Shigeo Murayama; Sung Hee Hwang; Shinji Saiki; Wado Akamatsu; Nobutaka Hattori; Bruce D Hammock; Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

Review 4.  Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings.

Authors:  Kenji Hashimoto
Journal:  Curr Psychiatry Rep       Date:  2019-07-05       Impact factor: 5.285

Review 5.  Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.

Authors:  Karen M Wagner; Cindy B McReynolds; William K Schmidt; Bruce D Hammock
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

Review 6.  Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders.

Authors:  Jiajing Shan; Kenji Hashimoto
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

7.  Maternal glyphosate exposure causes autism-like behaviors in offspring through increased expression of soluble epoxide hydrolase.

Authors:  Yaoyu Pu; Jun Yang; Lijia Chang; Youge Qu; Siming Wang; Kai Zhang; Zhongwei Xiong; Jiancheng Zhang; Yunfei Tan; Xingming Wang; Yuko Fujita; Tamaki Ishima; Debin Wang; Sung Hee Hwang; Bruce D Hammock; Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-12       Impact factor: 11.205

8.  In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea.

Authors:  Debin Wan; Jun Yang; Cindy B McReynolds; Bogdan Barnych; Karen M Wagner; Christophe Morisseau; Sung Hee Hwang; Jia Sun; René Blöcher; Bruce D Hammock
Journal:  Front Pharmacol       Date:  2019-05-08       Impact factor: 5.810

Review 9.  Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.

Authors:  Mercè Pallàs; Santiago Vázquez; Coral Sanfeliu; Carles Galdeano; Christian Griñán-Ferré
Journal:  Biomolecules       Date:  2020-05-01

10.  Ingestion of Faecalibaculum rodentium causes depression-like phenotypes in resilient Ephx2 knock-out mice: A role of brain-gut-microbiota axis via the subdiaphragmatic vagus nerve.

Authors:  Siming Wang; Tamaki Ishima; Youge Qu; Jiajing Shan; Lijia Chang; Yan Wei; Jiancheng Zhang; Yaoyu Pu; Yuko Fujita; Yunfei Tan; Xingming Wang; Li Ma; Xiayun Wan; Bruce D Hammock; Kenji Hashimoto
Journal:  J Affect Disord       Date:  2021-06-11       Impact factor: 6.533
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.